GALECTIN THERAPEUTICS INC — Director's Dealing 2018

Apr 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2018-04-16

Reporting Person: ZUCCONI THEODORE DANIEL (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-16	Common Stock	M	4000	$.89	Acquired	5083	Direct
2018-04-16	Common Stock	S	4000	$3.58	Disposed	1083	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-16	Stock option (right to buy)	$.89	M	4000	Disposed	2026-12-15	Common stock (4000)	Direct

Footnotes

F1: The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.